{"paper_id":"04e8b75f-c807-4632-bf48-9c95d56591a5","body_text":"Elizabeth L. Wolfe:  Writing – original draft.  LaTasha B. Craig:  Writing – review & editing.\n\nE.L.W. has nothing to disclose. L.B.C. reports funding from Oklahoma Shared Clinical and Translational Resource Institute NIGMS U54GM104938, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH/NICHD, Presbyterian Health Foundation, OU College of Medicine Alumni Association; honoraria and travel support from Ferring Pharmaceuticals; planned and pending patent: methods and compositions for treating diseases and conditions associated with gonadotropin-releasing hormone receptor.\" (Application: February 23, 2018); and a leadership role in the American Board of Obstetrics and Gynecology division of Reproductive Endocrinology & Infertility.","source_license":"CC0","license_restricted":false}